Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma

Shanghai Zhongshan Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
carcinomahepatocellularcarcinomapembrolizumab
carcinoma, hepatocellular, hepatocellular carcinoma, neoadjuvant therapy, pembrolizumab, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918108
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.